73 documents found, page 1 of 8
Grupo de Trabalho em BioArqueologia Portuguesa
Curto, Ana; Lopes, Célia; Detry, C; Ferreira, C; Tereso, JP; Almeida, NJ; Monteiro, P; Godinho, RM; Navarrete, Vna
Relatório científico da Expedição Oceano Azul - Cascais | Mafra | Sintra
Cabral, H; Afonso, CML; Almada, F; Almeida, S; Alonso, H; Andrade, J; Anjos, M; Batista, M; Bentes, L; Carvalho, AC; Celestino, S; Coelho, PD; Coxey, MA zona marítima dos concelhos de Cascais, Mafra e Sintra tem sido pouco estudada, não obstante situar-se frente a grandes centros urbanos e ser alvo de diversos usos e atividades humanas. Algumas das suas características geográficas e dos seus elementos notáveis ao nível dos fundos marinhos acrescem o seu interesse científico e patrimonial. Com o objectivo de ampliar o conhecimento científico sobre a biodiversi...
Setting Performance Indicators for Coastal Marine Protected Areas: An Expert-Ba...
Cardoso-Andrade, M; Queiroga, H; Rangel, M; Sousa, I; Belackova, A; Bentes, L; Oliveira, F; Monteiro, P; Sales Henriques, N; Afonso, CML; Silva, AFMarine Protected Areas (MPAs) require effective indicators to assess their performance, in compliance with the goals of relevant national and international commitments. Achieving and prioritizing shortlists of multidisciplinary indicators demands a significant effort from specialists to depict the multiple conservation and socioeconomic interests, and the large complexity of natural systems. The present paper d...
Catálogo da exposição “Áreas Marinhas Protegidas da Costa Sudoeste”
Quintella, BR; Horta e Costa, B; Pinto, B; Silva, AF; Sousa, I; Antunes, M; Coelho, P; Costa, JL; Almeida, PR; Marques, JP; Teodoro, PF; Costa, ACatálogo da exposição “Áreas Marinhas Protegidas da Costa Sudoeste”.
Áreas Marinhas Protegidas da Costa Sudoeste
Quintella, BR; Horta e Costa, B; Costa, JL; Silva, AF; Sousa, I; Antunes, M; Coelho, P; Pinto, B; Costa, T; Almeida, P. R.; Marques, JP; Teodoro, PFÁreas Marinhas Protegidas da Costa Sudoeste.
Management of ibrutinib treatment in patients with B-cell malignancies: clinica...
Carda, JP; Santos, L; Mariz, JM; Monteiro, P; Gonçalves, HM; Raposo, J; Silva, MGObjectives: Ibrutinib, a potent inhibitor of the Bruton tyrosine kinase, has revolutionized the treatment of many B-cell malignancies. Ibrutinib has an established favorable toxicity profile with up to 8 years of experience in clinical trials; however, despite ibrutinib’s favorable toxicity profile, dose reductions and treatment discontinuations are becoming more evident in clinical practice, particularly in th...
Cuidados Intensivos Cardíacos em Portugal: Projetar a Mudança
Monteiro, S; Timóteo, AT; Caeiro, D; Silva, M; Tralhão, A; Guerreiro, C; Silva, D; Aguiar, C; Santos, J; Monteiro, P; Gil, V; Morais, JIn recent years, the number of patients requiring acute cardiac care has increased, with progressively more complex cardiovascular conditions, often complicated by acute or chronic non-cardiovascular comorbidities, which affects the management and prognosis of these patients. Coronary care units have evolved into cardiac intensive care units, which provide highly specialized health care for the critical heart p...
Effect of empagliflozin beyond glycemic control: Cardiovascular benefit in pati...
Monteiro, P; Aguiar, C; Matos, P; Silva-Nunes, J; Birne, R; Branco, P; Calado, J; Melo, M; Polónia, JThe prevalence of type 2 diabetes (T2D) continues to increase, and its association with cardiovascular (CV) disease has led to the inclusion of CV endpoints in clinical trials on the treatment of T2D. This article explores the various trials already performed and under development in this field, with particular focus on the EMPA-REG OUTCOME trial. In this trial, empagliflozin, a sodium-glucose co-transporter 2 ...
Effect of Empagliflozin Beyond Glycemic Control: Cardiovascular Benefit in Pati...
Monteiro, P; Aguiar, C; Matos, P; Silva-Nunes, J; Birne, R; Branco, P; Calado, J; Melo, M; Polónia, JThe prevalence of type 2 diabetes (T2D) continues to increase, and its association with cardiovascular (CV) disease has led to the inclusion of CV endpoints in clinical trials on the treatment of T2D. This article explores the various trials already performed and under development in this field, with particular focus on the EMPA-REG OUTCOME trial. In this trial, empagliflozin, a sodium-glucose co-transporter 2 ...
The retable of the chapel of Our Lady of Mercy in the cloister of Oporto’s Cath...
Monteiro, P; Frade, JC; Barata, C; Candeias, AThe retable located in the Chapel of Our Lady of Mercy, in the cloisters of Oporto’s cathedral, dates back to the 17th century. Artistically, it belongs to a transition period between the Mannerism and the Baroque styles. The artistic value and the lack of documented information about the artwork led to the development of a project contemplating its the study. Both chemical and physical analyses - observation o...